Eli Lilly and Company and AtaiBeckley Inc. announced a agreement for Lilly to acquire AtaiBeckley. The transaction features cash consideration of $6.75 per share,...
AstraZeneca announced a exclusive global license agreement with Dizal Pharmaceutical to develop and commercialize Zegfrovy (sunvozertinib), a highly differentiated, oral irreversible EGFR inhibitor designed for targeted lung cancer...
VerGo Pharma, a leading Contract Research Organization (CRO), announced the successful completion of an unannounced United States Food and Drug Administration (US FDA) inspection at...
Prime Minister Shri Narendra Modi today dedicated major healthcare infrastructure expansions at the Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, marking...
Jasper Therapeutics (Nasdaq: JSPR) has finalized its all-stock acquisition of Kira Pharmaceuticals, forming a combined entity focused on treatments for immune-related conditions. Alongside the...